Anti-Human IgG antibody [EPR4421] (Ab109489)
Immunoglobulin heavy constant gamma 1, Ig gamma-1 chain C region, Ig gamma-1 chain C region EU, Ig gamma-1 chain C region KOL, Ig gamma-1 chain C region NIE, IGHG1
详细信息
特异性
This antibody recognizes all four Human IgG isotypes (IgG1, IgG2, IgG3, and IgG4).
背景信息
Product Specifications Anti-Human IgG antibody [EPR4421] (ab109489) was developed by Abcam using patented rabbit monoclonal antibody technology and is validated for use in IHC-P, WB in human samples. Anti-Human IgG antibody [EPR4421] (ab109489) specifically detects Human IgG (UniProt ID: P01857; Molecular weight: 44kDa) and is sold in 100 µL and 1 mL selling sizes. Quality and Validation Abcam's high quality manufacturing and validation processes ensure Anti-Human IgG antibody [EPR4421] (ab109489) has high sensitivity and specificity alongside high lot-to-lot consistency and reproducibility. Anti-Human IgG antibody [EPR4421] (ab109489) has been cited over 311 times in peer reviewed journals and is trusted by the scientific community. Related Products Conjugation-ready, carrier free format available for antibody clone EPR4421 - ab226069. Antibody clone EPR4421 is also available pre-conjugated to a variety of labels for your convenience - Alexa Fluor® 647, Alexa Fluor® 488, Biotin ( ab307521, ab307524, ab314397 ). Species reactivity Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species. Please contact us for more information. Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents. What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies.
文献引用 (320)
Endothelial progenitor cell derived extracellular vesicles promotes wound healing in diabetic mice via activating mobilization and neovascularization.
内皮祖细胞衍生的细胞外囊泡通过激活动员和新生血管形成来促进糖尿病小鼠的伤口愈合。
Lactate regulates the YTHDF2-FTH1 axis to promote cardiomyocyte ferroptosis and aggravate myocardial ischemia-reperfusion injury.
乳酸调节 YTHDF2-FTH1 轴,促进心肌细胞铁死亡,加重心肌缺血再灌注损伤。
MicroRNAâ199aâ3p suppresses nonâsmall cell lung cancer progression by targeting FTO to enhance m6Aâmediated downregulation of MZF1 and its transcriptional activation of CLDND1.
MicroRNA'199a'3p 通过靶向 FTO 来抑制非小细胞肺癌的进展,从而增强 m6A' 介导的 MZF1 下调及其对 CLDND1 的转录激活。
IgG4-Related Disease Manifested as Hypertrophic Pachymeningitis: A Case Report and Literature Review.
IgG4相关疾病表现为肥厚性硬脑膜炎:病例报告及文献综述。
Hypoxia Triggers ALYREF-Mediated m(5)C Methylation of KIF20A to Activate KIF20A/BUB1 for Generating Ferroptosis Resistance in Cervical Cancer Cells.
缺氧触发 ALYREF 介导的 KIF20A m(5)C 甲基化,从而激活 KIF20A/BUB1,使宫颈癌细胞产生铁死亡抵抗力。
ALDH1 and ALCAM as emerging biomarkers in personalized rectal cancer therapy.
ALDH1 和 ALCAM 作为直肠癌个性化治疗中的新兴生物标志物。
ALKBH5 promotes inflammation and inhibits osteogenic differentiation by activating the TLR9/MAPK pathway in human periodontal ligament stem cells.
ALKBH5 通过激活人牙周膜干细胞中的 TLR9/MAPK 通路来促进炎症并抑制成骨分化。
Oncolytic immunotherapy with nivolumab in muscle-invasive bladder cancer: a phase 1b trial.
纳武利尤单抗溶瘤免疫疗法治疗肌层浸润性膀胱癌:一项 1b 期试验
Intravaginal delivery of mRNA-encoded antibodies with enhanced breadth and potency for SHIV/HIV protection
阴道内递送mRNA编码抗体,增强其广谱性和效力,用于SHIV/HIV保护
- 1
- 2
- 3
- 4
- 5
- 6
- 32